• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2); AHBS2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2); AHBS2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/25/2019
Event Type  malfunction  
Manufacturer Narrative
The type of blood collection tube used was lithium heparinize plasma tube from bd.The sample was not tested with multi-diluent 11 with the atellica im (b)(6) assay.The patient was not vaccinated for (b)(6).The customer had a patient sample that recovered positive (198.17 iu/ml) with the atellica im (b)(6) assay on (b)(6) 2019 but was negative on two alternate methods.When the sample was tested on another atellica im system, it recovered positive (~200 iu/ml).The sample was also (b)(6) reactive (>1000 index).The data provided by the customer showed the sample recovered 339.98 miu/ml on s/n/ (b)(4) with atellica im (b)(6) lot 109 on (b)(6) 2019 and 301.53 miu/ml on s/n (b)(4) with atellica im (b)(6) lot 117 on (b)(6) 2019.Siemens reviewed the calibration data provided and there is no evidence of a problem.The customer was not able to provide the patient's medical status or a list of medications/supplements the patient is taking.There is no sample that can be sent to siemens for evaluation.The clinical sensitivity and specificity section of the atellica im (b)(6) surface antigen 2 ((b)(6)) instructions for use (ifu) (10995277, revision 03, 2019-04) lists the 95% confidence interval (ci) for resolved relative specificity as 98.34% - 99.88% so a certain number of false positive results can be expected for this assay.This one false positive result does not indicate a product problem with atellica im (b)(6) lots 109 and 117.The cause of the false positive result seen by the customer when using atellica im (b)(6) lots 109 and 117 could not be determined but siemens cannot rule out pre-analytical factors, a sample issue, or normal assay performance.Based on the investigation, no product problem was identified.The instrument is performing within specifications.No further evaluation of the device is required.The ifu states in the interpretation of results section: "results should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." mdr 1219913-2019-00224, 1219913-2019-00225 and 1219913-2019-00226 were filed for the same event.
 
Event Description
A discordant positive atellica im (b)(6) surface antigen 2 ((b)(6)) result was obtained for a patient sample.The (b)(6) result for the patient sample was positive.The customer tested the patient sample on two alternate methods and the results were negative.The patient sample was run on another atellica im system by the siemens' field application specialist (fas) and the result was positive.The patient sample was run on both atellica im systems on another day and the results were positive.The positive result was not reported to the physician.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the (b)(6) results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2)
Type of Device
AHBS2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
e. walpole MA 02032
Manufacturer Contact
eiman sulieman
333 coney street
e. walpole,, MA 02032
5086604603
MDR Report Key9287829
MDR Text Key220623926
Report Number1219913-2019-00227
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00630414597836
UDI-Public00630414597836
Combination Product (y/n)N
Reporter Country CodeVM
PMA/PMN Number
P100039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/06/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/28/2020
Device Model NumberN/A
Device Catalogue Number10995453
Device Lot Number66240117
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/25/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/28/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-